Lysine 63-linked TANK-binding kinase 1 ubiquitination by Mindbomb E3 ubiquitin protein ligase 2 is mediated by the mitochondrial antiviral signaling protein

Journal of Virology

Volumn 88, Issue 21, 2014, Pages 12765-12776

  Ye, Jung Sook ^a   Kim, Nari ^a   Lee, Kyoung Jin ^a   Nam, Young Ran ^a   Lee, Uk ^a   Joo, Chul Hyun ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA6 INTERFERON; GREEN FLUORESCENT PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; LYSINE; MINDBOMB UBIQUITIN PROTEIN LIGASE E3; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; PHOSPHOTRANSFERASE; TANK BINDING KINASE 1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS PROTEIN; BETA INTERFERON; IRF3 PROTEIN, HUMAN; IRF7 PROTEIN, HUMAN; MIB2 PROTEIN, HUMAN; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TBK1 PROTEIN, HUMAN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; VISA PROTEIN, HUMAN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOPHOSPHORYLATION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE ACTIVATION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; IRF3 GENE; IRF7 GENE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; UBIQUITINATION; VESICULAR STOMATITIS VIRUS; VIRUS REPLICATION; BINDING SITE; CELL LINE; CENTRIFUGATION; IMMUNOLOGY; METABOLISM; SECRETION (PROCESS); SENDAI VIRUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID MOTIFS; BINDING SITES; CELL LINE; CENTRIFUGATION; DNA MUTATIONAL ANALYSIS; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON-BETA; LYSINE; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; SENDAI VIRUS; SIGNAL TRANSDUCTION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84907978513     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02037-14     Document Type: Article

References (43)

1. Liu Y-J. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23:275-306. http://dx.doi.org/10.1146/annurev.immunol.23.021704.115633.
2. Levy DE, Marié IJ, Durbin JE. 2011. Induction and function of type I and III interferon in response to viral infection. Curr. Opin. Virol. 1:476-486. http://dx.doi.org/10.1016/j.coviro.2011.11.001.
3. de Weerd NA, Samarajiwa SA, Hertzog PJ. 2007. Type I interferon receptors: biochemistry and biological functions. J. Biol. Chem. 282: 20053-20057. http://dx.doi.org/10.1074/jbc.R700006200.
4. Fu XY, Kessler DS, Veals SA, Levy DE, Darnell JE. 1990. ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. Proc. Natl. Acad. Sci. U. S. A. 87:8555-8559 http://dx.doi.org/10.1073/pnas.87.21.8555.
5. Guan K, Zheng Z, Song T, He X, Xu C, Zhang Y, Ma S, Wang Y, Xu Q, Cao Y, Li J, Yang X, Ge X, Wei C, Zhong H. 2013. MAVS regulates apoptotic cell death by decreasing K48-linked ubiquitination of voltagedependent anion channel 1. Mol. Cell. Biol. 33:3137-3149. http://dx.doi.org/10.1128/MCB.00030-13.
6. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801. http://dx.doi.org/10.1016/j.cell.2006.02.015.
7. Walsh D, McCarthy J, O' Driscoll C, Melgar S. 2013. Pattern recognition receptors-molecular orchestrators of inflammation in inflammatory bowel disease. Cytokine Growth Factor Rev. 24:91-104. http://dx.doi.org /10.1016/j.cytogfr.2012.09.003.
8. Dixit E, Boulant S, Zhang Y, Lee ASY, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC. 2010. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141:668-681. http://dx.doi.org/10.1016/j.cell.2010.04.018.
9. Horner SM, Liu HM, Park HS, Briley J, Gale M. 2011. Mitochondrialassociated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 108:14590-14595. http://dx.doi.org/10.1073/pnas.1110133108.
10. Hou F, Sun L, Zheng H, Skaug B, Jiang Q-X, Chen ZJ. 2011. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146:448-461. http://dx.doi.org/10.1016/j.cell.2011.06.041.
11. Seth RB, Sun L, Ea C-K, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell 122:669-682. http://dx.doi.org/10.1016/j.cell.2005.08.012.
12. Xu L-G, Wang Y-Y, Han K-J, Li L-Y, Zhai Z, Shu H-B. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19:727-740. http://dx.doi.org/10.1016/j.molcel.2005.08.014.
13. Sharma S. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151. http://dx.doi.org/10.1126 /science.1081315.
14. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539-548. http: //dx.doi.org/10.1016/S1074-7613(00)00053-4.
15. tenOever BR, Sharma S, Zou W, Sun Q, Grandvaux N, Julkunen I, Hemmi H, Yamamoto M, Akira S, Yeh W-C, Lin R, Hiscott J. 2004. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis vi-rus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity. J. Virol. 78:10636-10649. http://dx.doi.org /10.1128/JVI.78.19.10636-10649.2004.
16. Honda K, Takaoka A, Taniguchi T. 2006. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25:349-360. http://dx.doi.org/10.1016/j.immuni.2006.08.009.
17. Paz S, Vilasco M, Werden SJ, Arguello M, Joseph-Pillai D, Zhao T, Nguyen TL-A, Sun Q, Meurs EF, Lin R, Hiscott J. 2011. A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response. Cell Res. 21:895-910. http: //dx.doi.org/10.1038/cr.2011.2.
18. Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, Perry A, Cheng G. 2006. Critical role of TRAF3 in the Toll-like receptordependent and-independent antiviral response. Nature 439:208-211. http://dx.doi.org/10.1038/nature04374.
19. Saha SK, Pietras EM, He JQ, Kang JR, Liu S-Y, Oganesyan G, Shahangian A, Zarnegar B, Shiba TL, Wang Y, Cheng G. 2006. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 25:3257-3263. http://dx.doi.org /10.1038/sj.emboj.7601220.
20. Zeng W, Xu M, Liu S, Sun L, Chen ZJ. 2009. Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol. Cell 36:315-325 http://dx.doi.org/10.1016/j.molcel.2009.09.037.
21. Cole C, Barber JD, Barton GJ. 7 May 2008. The Jpred 3 secondary structure prediction server. Nucleic Acids Res. http://dx.doi.org/10.1093 /nar/gkn238.
22. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, Thompson JD, Higgins DG. 11 October 2011. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. http://dx.doi.org/10.1038/msb.2011.75.
23. Crooks GE, Hon G, Chandonia J-M, Brenner SE. 2004. WebLogo: a sequence logo generator. Genome Res. 14:1188-1190. http://dx.doi.org /10.1101/gr.849004.
24. Joo C-H, Lee U, Nam YR, Jung JU, Lee H, Cho YK, Kim YK. 2010. Gene therapeutic approach for inhibiting hepatitis C virus replication using a recombinant protein that controls interferon expression. Antimicrob. Agents Chemother. 54:5048-5056. http://dx.doi.org/10.1128/AAC.00682-10.
25. Joo C-H, Shin YC, Gack M, Wu L, Levy D, Jung JU. 2007. Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi' s sarcoma-associated herpesvirus viral IRF homolog vIRF3. J. Virol. 81:8282-8292. http://dx.doi.org/10.1128/JVI.00235-07.
26. Caillaud A, Prakash A, Smith E, Masumi A, Hovanessian AG, Levy DE, Marié I. 2002. Acetylation of interferon regulatory factor-7 by p300/ CREB-binding protein (CBP)-associated factor (PCAF) impairs its DNA binding. J. Biol. Chem. 277:49417-49421. http://dx.doi.org/10.1074/jbc.M207484200.
27. Friedman CS, O' Donnell MA, Legarda-Addison D, Ng A, Cárdenas WB, Yount JS, Moran TM, Basler CF, Komuro A, Horvath CM, Xavier R, Ting AT. 2008. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep. 9:930-936. http://dx.doi.org/10.1038/embor.2008.136.
28. Eisenächer K, Krug A. 2012. Regulation of RLR-mediated innate immune signaling-it is all about keeping the balance. Eur. J. Cell Biol. 91:36-47. http://dx.doi.org/10.1016/j.ejcb.2011.01.011.
29. Williamson MP. 1994. The structure and function of proline-rich regions in proteins. Biochem. J. 297(Pt 2):249-260.
30. Belgnaoui SM, Paz S, Hiscott J. 2011. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr. Opin. Immunol. 23:564-572. http://dx.doi.org/10.1016/j.coi.2011.08.001.
31. Tenoever BR, Ng S-L, Chua MA, McWhirter SM, García-Sastre A, Maniatis T. 2007. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315:1274-1278. http://dx.doi.org/10.1126/science.1136567.
32. Wang L, Li S, Dorf ME. 2012. NEMO binds ubiquitinated TANKbinding kinase 1 (TBK1) to regulate innate immune responses to RNA viruses. PLoS One 7:e43756. http://dx.doi.org/10.1371/journal.pone.0043756.
33. Häcker H, Karin M. 2006. Regulation and function of IKK and IKKrelated kinases. Sci. STKE 2006:re13. http://dx.doi.org/10.1126/stke.3572006re13.
34. Takeuchi T, Heng HHQ, Ye CJ, Liang S-B, Iwata J, Sonobe H, Ohtsuki Y. 2003. Down-regulation of a novel actin-binding molecule, skeletrophin, in malignant melanoma. Am. J. Pathol. 163:1395-1404. http://dx.doi.org/10.1016/S0002-9440(10)63497-9.
35. Takeuchi T, Adachi Y, Ohtsuki Y. 2005. Skeletrophin, a novel RING molecule controlled by the chromatin remodeling complex, is downregulated in malignant melanoma. DNA Cell Biol. 24:339-344. http://dx.doi.org/10.1089/dna.2005.24.339.
36. Takeuchi T, Adachi Y, Sonobe H, Furihata M, Ohtsuki Y. 2006. A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion. Oncogene 25:7059-7069. http://dx.doi.org/10.1038/sj.onc.1209688.
37. Nguyen HT, Voza F, Ezzeddine N, Frasch M. 2007. Drosophila mind bomb2 is required for maintaining muscle integrity and survival. J. Cell Biol. 179:219-227. http://dx.doi.org/10.1083/jcb.200708135.
38. Barsi JC, Rajendra R, Wu JI, Artzt K. 2005. Mind bomb1 is a ubiquitin ligase essential for mouse embryonic development and Notch signaling. Mech. Dev. 122:1106-1117. http://dx.doi.org/10.1016/j.mod.2005.06.005.
39. Koo B-K, Yoon M-J, Yoon K-J, Im S-K, Kim Y-Y, Kim C-H, Suh P-G, Jan YN, Kong Y-Y. 2007. An obligatory role of mind bomb-1 in notch signaling of mammalian development. PLoS One 2:e1221. http://dx.doi.org/10.1371/journal.pone.0001221.
40. Matsuda A, Suzuki Y, Honda G, Muramatsu S, Matsuzaki O, Nagano Y, Doi T, Shimotohno K, Harada T, Nishida E, Hayashi H, Sugano S. 2003 Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22:3307-3318 http://dx.doi.org/10.1038/sj.onc.1206406.
41. Li S, Wang L, Berman M, Kong Y-Y, Dorf ME. 2011. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 35:426-440. http://dx.doi.org/10.1016 /j.immuni.2011.06.014.
42. Koo B-K, Yoon K-J, Yoo K-W, Lim H-S, Song R, So J-H, Kim C-H, Kong Y-Y. 2005. Mind bomb-2 is an E3 ligase for Notch ligand. J. Biol. Chem. 280:22335-22342. http://dx.doi.org/10.1074/jbc.M501631200.
43. Moresco EMY, Vine DL, Beutler B. 2011. Prion-like behavior of MAVS in RIG-I signaling. Cell Res. 21:1643-1645. http://dx.doi.org/10.1038/cr.2011.155.